Pliant Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
331 Oyster Point Boulevard, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
8/7/2024, 04:16 PM
Form type Sec Links Description Filing date Reporting date
SC 13G Report SC 13G Feb 14, 2024
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G Report Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G Report SCHEDULE 13G Feb 13, 2024
SC 13G/A Report Feb 9, 2024
SC 13G Report Feb 8, 2024
SC 13G Report Jan 25, 2024
SC 13G Report Mar 20, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report CHI ADVISORS LLC Feb 13, 2023
SC 13G/A Report Feb 9, 2023
SC 13G/A Report SC 13G/A Aug 31, 2022
SC 13G/A Report Aug 10, 2022
SC 13G/A Report Jun 10, 2022
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report CHI ADVISORS LLC Feb 11, 2022
SC 13G/A Report Feb 9, 2022
SC 13G Report CHI ADVISORS LLC Mar 2, 2021
SC 13G Report SC 13G Feb 16, 2021
SC 13G/A Report SCHEDULE 13G/A Feb 16, 2021
SC 13G Report SC 13G Feb 12, 2021
SC 13G/A Report Feb 8, 2021
SC 13G Report Jul 10, 2020
SC 13G Report SC 13G Jun 15, 2020
SC 13G Report SC 13G Jun 9, 2020